November 09, 2018
Research presented at major liver conference showcases the B.C. Centre for Disease Control’s work to understand hepatitis burden and the impact of interventions.
New curative treatments for hepatitis C reduce complications and the risk of dying, finds new research from the B.C. Centre for Disease Control (BCCDC).
“As hepatitis C shifts from a chronic disease to a curable illness, it is important to understand what this means for patients and the health care system,” said Dr. Mel Krajden, medical head of hepatitis at the BCCDC. “We are fortunate enough to be able to examine population outcomes and share the insights with people from around the world.”
BCCDC scientists and researchers are presenting 12 abstracts at the 2018 American Association for the Study of Liver Disease’s (AASLD) Liver Meeting.
During and after the Liver Meeting this blog will link to impactful conference news reported by HCV advocacy and support organizations, patient-bloggers, interested media outlets, and of course the AASLD website.
View all updates on this blog, (LINK), coverage elsewhere, (LINK).
No comments:
Post a Comment